Stop parsing PDFs. Get the API. Request Access

AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Fresenius SE & Co. KGaA

Earnings Release • Sep 6, 2016

166_ip_2016-09-06_72c467c1-6860-4ab3-92bc-bdba32c89e53.pdf

Earnings Release

Open in Viewer

Opens in native device viewer

Acquisition of Quirónsalud

Bad Homburg, 6 September 2016

Safe Harbor Statement

This presentation contains forward-looking statements that are subject to various risks and uncertainties. Future results could differ materially from those described in these forward-looking statements due to certain factors, e.g. changes in business, economic and competitive conditions, regulatory reforms, results of clinical trials, foreign exchange rate fluctuations, uncertainties in litigation or investigative proceedings, and the availability of financing. Fresenius does not undertake any responsibility to update the forward-looking statements contained in this presentation.

Transaction Highlights

Strong management team with proven track recordand ongoing commitment to Fresenius

  • Combination forms powerful platform for knowledge & best practice transfer
  • Substantialcost and growth synergies

Highly accretive from 2017 – leverage back to current levels after 1.5 years

New mid-term targets for Fresenius Group as part of its FY 2016 reporting

Excellent Reputation in the Spanish Hospital Market

Quirónsalud – Corporate History

Hospital Network With Clear Focus on Large Metropolitan Areas

Spanish Health Care Market – Key Facts

Total health care expenditure

Average length of stay

Hospital discharges

Hospital beds

Private Health Care System in Spain

NHS = National Health Care System; HIC = Health Insurance Companies * Expectation: mid-term CAGR +1.5%

Broad Revenue Base of Quirónsalud Driven by Diversified Payor and Patient Split

34%12%8%43%3%Other€2,372m RevenuesTotal 2015 Private - HIC Agreements with all relevant HICs Full reimbursement of all medical services Self pay Treatments not covered by HIC/NHS (e.g. plastic surgery, dental and drugs) Medical tourismPublic – NHS (PPPs) • 5 long-term concession hospitals 4 in Madrid and 1 in Barcelona• Remuneration per capita within assigned coverage area, additional remuneration for "free-choice" patients Occupational Risk Prevention • Only private hospital provider with ORP services in Spain ~300 centers:>4m employees contracted; >1.7m check-ups p.a.

•Cross-selling opportunities

HIC = Health Insurance Companies; NHS = National Health Care System

•

•

•

•

Structural Growth Drivers

Health care expenditure per capita in Spain below EU average

Close dovetailing of inpatient and outpatient care

Public – NHS (PPPs)

Expansion of existing facilities

Greenfield projects

Acquisition of private hospitals

Financial Outlook

Financially Sound Acquisition (I)

i
i
D
t
e
p
r
e
c
a
o
n		 %
f
l
i
6
4
F
Y
1
o
s
a
e
s
n
;
•
~
d
f
f
l
l
i
g
o
o
p
r
o
x
y
o
r
o
o
w
n
g
y
e
a
r
s
i
i
A
t
t
m
o
r
z
a
o
n		 1
l
l
€
0
I
i
i
1
5
t
n
a
m
p
a
y
•
~
f
C
b
D
t
t
o
s
o
e		 2
0
%
•
~
T
t
a
x
r
a
e		 2
5
%
•
f.
b
i
i
E
A
T
t
t
e
a
m
o
a
o
n
r
z		 2
0
€
2
0
0
1
7
>
e
m
•
C
A
P
E
X		 f
l
i
4
%
F
Y
1
6
o
s
a
e
s
n
;
•
~
d
f
f
l
l
i
g
o
o
p
r
o
x
y
o
r
o
o
w
n
g
y
e
a
r
s

1preliminary, before final PPA

Financially Sound Acquisition (II)

l
i
d
i
T
t
t
o
a
c
o
n
s
e
a
o
n
r		 €
6
b
(
h
d
d
b
f
b
)
5
7
i
t-
n
o
n
a
c
a
s
a
n
e
r
e
e
a
s
s
•
1
A
1
0
8
E
B
I
T
D
A
2
0
1
7
p
p
o
x
e
r
x
•
i
i
F
n
a
n
c
n
g		 f
6
h
l
d
I
1
t
s
s
a
n
c
e
o
m
s
a
e
s
e
u
r
v
a
u
a
•
~
d
€
4
0
0
V
i
M
t
t
m
o
c
o
r
a
e
r
a
l
f
h
h
d
b
f
i
d
i
B
t
t
a
a
n
c
e
o
e
p
c
a
s
e
p
c
e
e
n
a
n
c
e
u
r
r
•
-
d
b
/
N
E
B
I
T
D
A
t
t
e
e		 f
2
0
1
6
3
1
p
o
o
m
a
r
r
x
•
~
b
k
i
h
i
2
0
1
2
3
0
7
t
5
e
a
c
n
a
n
g
e
w
x
r
•
‒

1based on mid-point of projected 2017 EBITDA range of €520 ‒ €550m

Integration by Interaction

Share Information

Share key facts

Number of shares1 546,652,116 Ticker symbol FRE Bloomberg symbol FRE GR Reuters symbol FREG.de

ADR key facts

Ticker symbol FSNUY Depositary bank Deutsche Bank

WKN / ISIN 578560 / DE0005785604

Ratio 4 ADRs = 1 ordinary share ADR CUSIP / ISIN 35804M105 / US35804M1053 Exchange OTCQX International Premier Structure Sponsored Level I ADR

1As of August 31, 2016

Financial Calendar / Contact

Financial Calendar 2016

27.10.2016 Report on 3rd quarter 2016

Please note that these dates could be subject to change.

Contact

Investor RelationsFresenius SE & Co. KGaAphone: +49 6172 608-2485 e-mail: [email protected] For further information and current news: www.fresenius.com

Follow us on Twitter www.twitter.com/fresenius_ir and LinkedIn: www.linkedin.com/company/fresenius-investor-relations

More from Fresenius SE & Co. KGaA

Declaration of Voting Results & Voting Rights Announcements 2025
Nov 17
Declaration of Voting Results & Voting Rights Announcements 2025
Nov 14
Report Publication Announcement 2025
Nov 6
Quarterly Report 2025
Nov 6
Interim / Quarterly Report 2025
Aug 6
Investor Presentation 2025
Aug 6
Declaration of Voting Results & Voting Rights Announcements 2025
Jul 4
Declaration of Voting Results & Voting Rights Announcements 2025
Jun 20
Governance Information 2025
May 23
Quarterly Report 2025
May 7
View all filings →

Talk to a Data Expert

Have a question? We'll get back to you promptly.